Evidence map›Paper›PMID 36557998›Full record

ArticleMolecules (Basel, Switzerland)2022

Chitosan-Based Ciprofloxacin Extended Release Systems: Combined Synthetic and Pharmacological (In Vitro and In Vivo) Studies.

Anton R Egorov, Aleh V Kurliuk, Vasili V Rubanik, Anatoly A Kirichuk, Omar Khubiev, Roman Golubev, Nikolai N Lobanov, Alexander G Tskhovrebov, Andreii S Kritchenkov

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Nanomaterials (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anton R EgorovFaculty of Science, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6, Moscow 117198, Russia.ORCID 0000-0002-6006-6883
Aleh V KurliukDepartment of General and Clinical Pharmacology, Vitebsk State Medical University, Frunze Av. 27, 210009 Vitebsk, Belarus.
Vasili V RubanikMetal Physics Laboratory, Institute of Technical Acoustics NAS of Belarus, Ludnikova Prosp. 13, 210009 Vitebsk, Belarus.
Anatoly A KirichukFaculty of Science, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6, Moscow 117198, Russia.
Omar KhubievFaculty of Science, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6, Moscow 117198, Russia.
Roman GolubevMetal Physics Laboratory, Institute of Technical Acoustics NAS of Belarus, Ludnikova Prosp. 13, 210009 Vitebsk, Belarus.
Nikolai N LobanovFaculty of Science, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6, Moscow 117198, Russia.
Alexander G TskhovrebovFaculty of Science, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6, Moscow 117198, Russia.ORCID 0000-0002-4445-2530
Andreii S KritchenkovFaculty of Science, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya St. 6, Moscow 117198, Russia.ORCID 0000-0002-6411-5988

Funding

RUDN University Strategic Academic Leadership Program 025238-2-174The Ministry of Education and Science of the Russian Federation 075-03-2020-223 (FSSF-2020-0017
6 · The paper itself

Abstract

Ciprofloxacin is one of the most effective antibiotics, but it is characterized by a range of side effects. Elaboration of drug-releasing systems which allow to diminish toxicity of ciprofloxacin is a challenging task in medicinal chemistry. The current study is focused on development of new ciprofloxacin releasing systems (CRS). We found that ultrasound efficiently promotes

Indexed as

ChitosanNanoparticlesAnimalsAnti-Bacterial AgentsChemistry, PharmaceuticalCiprofloxacinDrug LiberationRatsAnti-Bacterial AgentsChitosanCiprofloxacinantibacterial activitychitosanciprofloxacin

Identifiers

PMID36557998
PMCPMC9784460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.